The Medibank Private Ltd (ASX: MPL) share price is making little headway today. It is currently flat at $3.21 having earlier jumped to $3.25.
For comparison, the S&P/ASX 200 Index (ASX: XJO) is up 1.15% at the time of writing.
However, there is an interesting piece of news out of Medibank today. The private health insurance company has announced a new multi-million investment in a health technology company.
Let’s take a look.
Virtual health investment
Medibank has invested $10 million in the health technology company Medinet. The aim is to support the increasing role of virtual health in Australia.
Medinet is a digital platform providing patients with access to doctors online via video, audio, and chat. The platform was launched in 2019 and is being used in some GP clinics in Australia. The app is within the top five healthcare apps downloaded in the country.
Commenting on the investment, Medibank Group Executive – CEO Health Services Dr Andrew Wilson said:
People are looking for the same level of choice and convenience in their healthcare that they get in other parts of their lives. The COVID pandemic has accelerated the use and acceptance of technology-enabled healthcare, with recent research showing that 70% of Australians are willing to use virtual healthcare services.
Medinet’s platform supports this by giving patients the ability to make an appointment and connect with a GP virtually, to access scripts and referrals generated during the consult, and to have their medication delivered straight to their home.
Credit Suisse has recently rated the Medibank share price as a “buy” with a $3.50 price target. Medibank increased operating profit by 12.3% in the first half of FY22, while net profit after tax (NPAT) descended 2.7%. Policyholder numbers climbed 1.5% in the half while jumping 3.3% in 12 months.
On March 24, Medibank will pay a dividend of 6.1 cents per share.
Medibank share price recap
The Medibank share price has climbed 10% in the past 12 months, but it has fallen 4% year to date.
For perspective, the benchmark ASX 200 index has leapt 7% in the past 52 weeks.
In the past month, Medibank shares are in the red by 0.3% but they have jumped by 5% in the past week.
Medibank has a market capitalisation of about $8.9 billion based on its current share price.
The post Own Medibank (ASX:MPL) shares? Now you own a piece of this tech start-up appeared first on The Motley Fool Australia.
Should you invest $1,000 in Medibank right now?
Before you consider Medibank, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Medibank wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of January 13th 2022
More reading
- Healthy upside: Expert rates Medibank (ASX:MPL) share price as a good buy
- Leading brokers name 3 ASX shares to buy today
- Own Medibank (ASX:MPL) shares? Here’s all you need to know about the latest dividend
- Medibank (ASX:MPL) share price backtracks as profit slips
- ASX 200 (ASX:XJO) midday update: Block rockets, Blackmores sinks
The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/xzjF7Ui
Leave a Reply